Azelis
Short position disclosed on August 11, 2026.
0.71% of the capital sold short
1 disclosing funds
2 disclosures on record
BE0974400328 ISIN code
Funds holding Azelis Titelia
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Aug 1Aug 4Aug 7Aug 10Aug 13
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Capital Fund Management | 0.71% | +0.10 pt | August 11, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 11, 2026 | Capital Fund Management | 0.71% | still open |
| July 29, 2026 | Capital Fund Management | 0.61% | still open |
Other companies sold short in Belgium
- Solvay 2.07% of the capital sold short
- Biocartis 1.21% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- D'Ieteren Group 0.89% of the capital sold short
- Syensqo 0.89% of the capital sold short
- EVS 0.80% of the capital sold short
- Umicore 0.70% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- WDP 0.51% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Azelis, source FSMA, data as at August 11, 2026, https://www.quivad.com/action/azelis